이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

MeDe Study: Comparing Median Nerve Decompression at the Carpal Tunnel Alone Versus Median Nerve Decompression at Both the Carpal Tunnel and Lacertus Fibrosis in Adults With Carpal Tunnel Syndrome (MeDe)

2026년 6월 25일 업데이트: Maasstad Hospital

MeDe Study: A Randomized Controlled Trial Comparing Median Nerve Decompression at the Carpal Tunnel Alone Versus Median Nerve Decompression at Both the Carpal Tunnel and Lacertus Fibrosis in Adults With Carpal Tunnel Syndrome

Carpal tunnel syndrome (CTS) is a condition that can cause pain, numbness, or tingling in the hand and wrist. The most common surgery for CTS is called carpal tunnel release, which aims to relieve pressure on the main nerve in the wrist.

However, after this surgery, some patients (up to 4 out of 10) still have symptoms, and about 1 in 8 may need another surgery. One reason symptoms can continue is that the nerve may also be compressed higher up in the arm, near a ligament called the Lacertus fibrosus. Releasing this area might help, but it is often not checked or treated during the first surgery because current tests (like physical exams, nerve studies, and ultrasounds) cannot reliably detect it.

This study is comparing two approaches for people with CTS:

  1. Standard surgery - only releasing the carpal tunnel.
  2. Extended surgery - releasing both the carpal tunnel and the Lacertus fibrosus.

The goal is to see which surgery helps patients feel better and have fewer symptoms in the hand and wrist after treatment.

연구 개요

상세 설명

Carpal tunnel release is the most commonly performed surgical procedure in patients diagnosed with carpal tunnel syndrome (CTS). Nevertheless, up to 43% of patients experience residual symptoms, necessitating secondary surgical interventions in approximately one out of eight carpal tunnel releases.

These residual symptoms may be attributable to proximal median nerve compression (PMNC), which can potentially be alleviated by performing a Lacertus release. However, diagnosing PMNC poses a challenge, as standard diagnostic tools like physical examination, electromyography (EMG) and ultrasound lack the specificity to distinguish between CTS and PMNC. Consequently, PMNC often goes undetected and untreated during initial evaluations.

This randomised trial compares patient reported outcomes following median nerve decompression at the carpal tunnel alone versus median nerve decompression at both the carpal tunnel and the Lacertus fibrosus in individuals with CTS.

연구 유형

중재적

등록 (추정된)

110

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • South Holland
      • Rotterdam, South Holland, 네덜란드, 3079 DZ
        • 모병
        • Maasstad ziekenhuis
        • 연락하다:
        • 부수사관:
          • Sebastian Poggio Voormolen, BSc, PhD candidate
        • 부수사관:
          • Ileen Domela Nieuwenhuis Nyegaard, MD, PhD candidate
        • 수석 연구원:
          • Niels W.L Schep, MD, PhD
      • Rotterdam, South Holland, 네덜란드, 3201 GZ
        • 모병
        • Spijkenise Medisch Centrum
        • 연락하다:
        • 부수사관:
          • Sebastian Poggio Voormolen, BSc, PhD candidate
        • 부수사관:
          • Ileen Domela Nieuwenhuis Nyegaard, MD, PhD candidate
        • 수석 연구원:
          • Niels W.L Schep, MD, PhD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria:

  • Patients being at least 18 years or older
  • CTS confirmed by EMG or nerve ultrasound
  • Patient opts for surgical treatment

Exclusion Criteria:

  • Previous surgical decompression of the median nerve at the ipsilateral wrist or forearm
  • Severe thenar atrophy: Examination of the thenar is based on clinical observation. The presence of thenar muscle atrophy is scored as none, mild, or severe.
  • Simultaneous nerve decompression in the ipsilateral arm (e.g. cubital tunnel, Guyon and radial nerve release.
  • Neurological disorders affecting peripheral nerves (e.g. spinal cord compression or injury, muscular dystrophy, dystonia, ALS)
  • Malunion of the distal radius
  • Impaired hand function
  • Pregnancy
  • Inability to complete study forms due to insufficient comprehension of the Dutch language

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
다른: carpal tunnel release
Control group
Carpal tunnel release is a surgical procedure to treat carpal tunnel syndrome by cutting the ligament (transverse carpal ligament) covering the wrist's carpal tunnel. This action relieves pressure on the median nerve, alleviating pain, numbness, and weakness in the hand. It is usually an outpatient procedure done under local anesthesia.
다른: carpal tunnel release combined with Lacertus release
Intervention group
A transverse incision is made on the forearm's volar (anterior) aspect, approximately 3cm distal of the elbow crease. This incision is placed over the palpable brachioradialis and biceps tendon. The subcutaneous tissue is dissected to expose the fascia overlying the flexor pronator muscles. The brachial fascia is identified and incised to reveal the underlying Lacertus fibrosus (also known as the bicipital aponeurosis). The Lacertus fibrosus is a tendinous band extending from the biceps tendon medially across the forearm. Care is taken to avoid injury to the underlying structures, particularly the median nerve, which lies deep and slightly medial to the Lacertus fibrosus. The Lacertus fibrosus is incised transversely. The surgeon ensures that the median nerve is fully decompressed and that there are no remaining constrictive bands. It is usually an outpatient procedure done under local anesthesia.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ SSS)
기간: At twelve months follow-up
Scores range from 1 to 5. A higher score indicates a more severe level of impairment or discomfort.
At twelve months follow-up

2차 결과 측정

결과 측정
측정값 설명
기간
Pillar pain
기간: From 6 weeks after surgery until 12 months of follow-up
The presence of tenderness or pain in the thenar or hypothenar area around the hook of the hamate and the unciform process of the trapezium
From 6 weeks after surgery until 12 months of follow-up
(Return to) work using the QuickDASH work module.
기간: From enrollment until 6 months of follow-up.
From enrollment until 6 months of follow-up.
Sensibility
기간: From enrollment until 12 months of follow-up.
Monofilament test on the tuft of the 3rd digit and the proximal thenar. The tuft of the 5th digit and the distal thenar will be measured and used as a reference.
From enrollment until 12 months of follow-up.
Tip-pinch strength
기간: From enrollment until 12 months of follow-up
Tip-to-tip pinch strength of the first and second digit will be measured with a baseline pinch gauge.
From enrollment until 12 months of follow-up
Cost-effectiveness of intervention
기간: From enrollment until 12 months of follow-up
Measured with health care resource utilisation and costs (iMCQ, iPCQ).
From enrollment until 12 months of follow-up
Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ FSS)
기간: From enrollment until 12 months of follow-up
Scores range from 1 to 5. A higher score indicates a more severe level of impairment or discomfort.
From enrollment until 12 months of follow-up
Anchor questions
기간: At 12 months follow-up
Regarding patient satisfaction to analyse minimal clinically important difference (MCID)
At 12 months follow-up
Number of participants with residual, persistent en recurrent CTS symptoms
기간: From 6 weeks after surgery until 12 months of follow-up
From 6 weeks after surgery until 12 months of follow-up
Number of participants undergoing secondary surgery
기간: From 6 weeks until 12 months of follow-up.
This includes, but is not limited to, nerve decompression, internal or external neurolysis, and flap reconstruction in the ipsilateral arm.
From 6 weeks until 12 months of follow-up.
Number of participants that experienced complications or adverse events
기간: From enrollment until 12 months of follow-up.
Such as infection, seroma, and tendon and neurovascular damage.
From enrollment until 12 months of follow-up.
5-level EuroQol (EQ-5D-5L): Quality of life
기간: Will be assessed at baseline and at 12 months of follow-up.
Will be assessed using the 5-level EuroQol (EQ-5D-5L) questionnaire.
Will be assessed at baseline and at 12 months of follow-up.
Physical examination
기간: From enrollment until 12 months of follow-up.

OK-sign, FLP and FDP2 strength separately (compared to contralateral hand). Scratch collapse test over the carpal tunnel and Lacertus fibrosis (positive or negative).

Phalen and Tinel test (positive or negative).

From enrollment until 12 months of follow-up.
Exploratory ultrasound
기간: Will be assessed at baseline and 3 months.
Changes in median nerve cross-sectional diameter (mm) to evaluate postoperative changes in nerve size over time, measured by nerve ultrasound.
Will be assessed at baseline and 3 months.

기타 결과 측정

결과 측정
측정값 설명
기간
Patient Demographics
기간: At baseline
Age, sex, labour (blue versus white collar), hand dominance and medical history regarding comorbidities and hand-specific conditions
At baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 5월 6일

기본 완료 (추정된)

2028년 2월 1일

연구 완료 (추정된)

2028년 2월 1일

연구 등록 날짜

최초 제출

2026년 5월 11일

QC 기준을 충족하는 최초 제출

2026년 5월 11일

처음 게시됨 (실제)

2026년 5월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 6월 26일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 6월 25일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • NL-OMON57619
  • NL-005174 (레지스트리 식별자: CCMO: Research with human participants)
  • NL87289.100.2 (기타 식별자: ICTRP)
  • R24.082 (기타 식별자: MEC-U)

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다